Table 5.
Basic Information of MLL-r Positive ALL Relapse Cases
| No. | Age/Gender | WBC×109/L | PR | Immunophenotype | D15 BM |
D15 MRD | D33 BM | D33 MRD | Risk group | Partner gene |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 5 Month/Male | 895.54 | PGR | B | M3 | Positive | M1 | Positive | HR | MLL-ENL |
| 2 | 11 Month/Female | 3.87 | PGR | B | M1 | Negative | M1 | Negative | IR | MLL-ENL |
| 3 | 2 Year/Female | 169.95 | PPR | B | M1 | Positive | M1 | Negative | HR | MLL-AF4 |
| 4 | 2 Year/Female | 218 | PGR | T | M1 | Positive | M1 | Positive | HR | MLL-PTD |
Abbreviation: WBC white blood cell, SR standard risk, IR intermediate risk, HR high risk, PR prednisone response, PGR prednisone good response, PPR prednisone poor response, MRD minimal residual disease evaluation, BM bone marrow